Jump to content
RemedySpot.com

Key Interaction in Hepatitis C Virus Identified

Rate this topic


Recommended Posts

Posted

http://www.sciencedaily.com/releases/2010/12/101228180857.htm

Key Interaction in Hepatitis C Virus Identified

ScienceDaily (Dec. 28, 2010) — Scientists from the Florida campus of The Scripps

Research Institute have identified a molecular interaction between a structural

hepatitis C virus protein (HCV) and a protein critical to viral replication.

This new finding strongly suggests a novel method of inhibiting the production

of the virus and a potential new therapeutic target for hepatitis C drug

development.

The study was published in the January 2010 issue of the Journal of General

Virology.

These new data underline the essential role of the viral protein known as " core "

as a primary organizer of the infectious HCV particle assembly and support a new

molecular understanding of the formation of the viral particle itself.

" While our finding that the HCV core interacts with the non-structural helicase

protein was not totally unexpected, this had not really been confirmed until

this study, " said Scripps Florida Professor Donny Strosberg, who led the study.

" But the most exciting part is that small molecule inhibitors of dimerization

[the joining of two identical subunits] of core actually inhibit interaction

between core and helicase, thus possibly preventing production of an infectious

viral particle. "

A Viral Plague

Hepatitis C virus infects between 130 and 170 million people worldwide and is

the cause of an epidemic of liver cirrhosis and cancer. Because current HCV

treatments are only partially effective, a number of alternative molecular

mechanisms are actively being pursued as possible drug targets.

One of the critical problems of finding inhibitors for the hepatitis C virus is

that it mutates at such prodigious rates. An RNA virus such as hepatitis C can

mutate at a rate estimated as high as one million times that of DNA viruses such

as the herpes virus.

With this in mind, Strosberg has been examining the core protein, the most

conserved protein among all HCV genotypes. Core plays several essential roles in

the viral cycle in the host cell. It is particularly important in the assembly

of the hepatitis C nucleocapsid or capsid, an essential step in the formation of

infectious viral particles; the nucleocapsid is the virus genome protected by a

protein coat. By interacting with various structural and non-structural viral

proteins, core plays an essential role in the HCV cycle during assembly and

release of the infectious virus as well as disassembly of viral particles upon

entering host cells. Core also interacts with a number of cellular proteins,

possibly contributing to the disarmament of several host defense mechanisms and

to the activation of oncogenic pathways.

Last year, Strosberg developed a novel quantitative test for monitoring these

protein-protein interactions with the specific goal of identifying inhibitors of

the core dimerization, which would block virus production. Strosberg and his

colleagues uncovered peptides derived from the core protein of hepatitis C that

inhibit not only dimerization of the core protein, but also production of the

actual virus.

That earlier study led to the discovery of non-peptidic small organic molecules

that strongly inhibited HCV production, one of which, SL201, was used in the new

study.

In the new study, Strosberg and his colleagues focused on non-structural

proteins that provide functions relating to HCV production, in particular NS3

helicase. The scientists' findings support a growing body of evidence that this

protein participates in the assembly and production of infectious viral

particles. The interaction of the core protein with this non-structural protein

also confirms core as a key organizer of virus assembly and suggests it acts to

facilitate the packaging and integration of the newly synthesized viral RNA.

The study was supported by the state of Florida, The Factor Foundation, and the

National Institutes of Health.

Email or share this story:

| More

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff)

from materials provided by Scripps Research Institute.

Journal Reference:

G. Mousseau, S. Kota, V. Takahashi, D. N. Frick, A. D. Strosberg.

Dimerization-driven interaction of hepatitis C virus core protein with NS3

helicase. Journal of General Virology, 2010; 92 (1): 101 DOI:

10.1099/vir.0.023325-0

Posted

http://www.sciencedaily.com/releases/2010/12/101228180857.htm

Key Interaction in Hepatitis C Virus Identified

ScienceDaily (Dec. 28, 2010) — Scientists from the Florida campus of The Scripps

Research Institute have identified a molecular interaction between a structural

hepatitis C virus protein (HCV) and a protein critical to viral replication.

This new finding strongly suggests a novel method of inhibiting the production

of the virus and a potential new therapeutic target for hepatitis C drug

development.

The study was published in the January 2010 issue of the Journal of General

Virology.

These new data underline the essential role of the viral protein known as " core "

as a primary organizer of the infectious HCV particle assembly and support a new

molecular understanding of the formation of the viral particle itself.

" While our finding that the HCV core interacts with the non-structural helicase

protein was not totally unexpected, this had not really been confirmed until

this study, " said Scripps Florida Professor Donny Strosberg, who led the study.

" But the most exciting part is that small molecule inhibitors of dimerization

[the joining of two identical subunits] of core actually inhibit interaction

between core and helicase, thus possibly preventing production of an infectious

viral particle. "

A Viral Plague

Hepatitis C virus infects between 130 and 170 million people worldwide and is

the cause of an epidemic of liver cirrhosis and cancer. Because current HCV

treatments are only partially effective, a number of alternative molecular

mechanisms are actively being pursued as possible drug targets.

One of the critical problems of finding inhibitors for the hepatitis C virus is

that it mutates at such prodigious rates. An RNA virus such as hepatitis C can

mutate at a rate estimated as high as one million times that of DNA viruses such

as the herpes virus.

With this in mind, Strosberg has been examining the core protein, the most

conserved protein among all HCV genotypes. Core plays several essential roles in

the viral cycle in the host cell. It is particularly important in the assembly

of the hepatitis C nucleocapsid or capsid, an essential step in the formation of

infectious viral particles; the nucleocapsid is the virus genome protected by a

protein coat. By interacting with various structural and non-structural viral

proteins, core plays an essential role in the HCV cycle during assembly and

release of the infectious virus as well as disassembly of viral particles upon

entering host cells. Core also interacts with a number of cellular proteins,

possibly contributing to the disarmament of several host defense mechanisms and

to the activation of oncogenic pathways.

Last year, Strosberg developed a novel quantitative test for monitoring these

protein-protein interactions with the specific goal of identifying inhibitors of

the core dimerization, which would block virus production. Strosberg and his

colleagues uncovered peptides derived from the core protein of hepatitis C that

inhibit not only dimerization of the core protein, but also production of the

actual virus.

That earlier study led to the discovery of non-peptidic small organic molecules

that strongly inhibited HCV production, one of which, SL201, was used in the new

study.

In the new study, Strosberg and his colleagues focused on non-structural

proteins that provide functions relating to HCV production, in particular NS3

helicase. The scientists' findings support a growing body of evidence that this

protein participates in the assembly and production of infectious viral

particles. The interaction of the core protein with this non-structural protein

also confirms core as a key organizer of virus assembly and suggests it acts to

facilitate the packaging and integration of the newly synthesized viral RNA.

The study was supported by the state of Florida, The Factor Foundation, and the

National Institutes of Health.

Email or share this story:

| More

Story Source:

The above story is reprinted (with editorial adaptations by ScienceDaily staff)

from materials provided by Scripps Research Institute.

Journal Reference:

G. Mousseau, S. Kota, V. Takahashi, D. N. Frick, A. D. Strosberg.

Dimerization-driven interaction of hepatitis C virus core protein with NS3

helicase. Journal of General Virology, 2010; 92 (1): 101 DOI:

10.1099/vir.0.023325-0

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...